SCHEMBL25856195

SCHEMBL25856195

NC1CCC(N2CCC(CN3CCCCC3)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 2/20 0.53
ADRA2C P18825 1/20 0.53
ACHE P22303 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM1 P11229 1/20 0.35
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
OPRK1 P41145 1/20 0.35
OPRL1 P41146 1/20 0.35
MAPT P10636 2/20 0.34
TP53 P04637 1/20 0.34
HRH3 Q9Y5N1 4/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
CYP3A4 P08684 1/20 0.32
CYP2C9 P11712 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22570086 0.86 CHRM5 (0.53) CHRM5ADRA2CACHESMN1; SMN2KDM4E
SCHEMBL4132048 0.85 CHRM5 (0.67) CHRM5ADRA2CACHESMN1; SMN2OPRM1
SCHEMBL16271017 0.85 CHRM5 (0.67) CHRM5ADRA2CACHESMN1; SMN2OPRM1
SCHEMBL4132043 0.85 CHRM5 (0.67) CHRM5ADRA2CACHESMN1; SMN2OPRM1
SCHEMBL1204165 0.84 CHRM5 (0.42) CHRM5ADRA2CACHEKDM4ETDP1
SCHEMBL24474498 0.84 CHRM5 (0.50) CHRM5ADRA2CACHESMN1; SMN2KDM4E
SCHEMBL30697248 0.84 CHRM5 (0.50) CHRM5ADRA2CACHESMN1; SMN2KDM4E
SCHEMBL842660 0.83 CHRM5 (0.39) CHRM5ADRA2CACHEKDM4ETDP1
SCHEMBL372637 0.83 CHRM5 (0.39) CHRM5ADRA2CACHEKDM4ETDP1
SCHEMBL372638 0.83 CHRM5 (0.39) CHRM5ADRA2CACHEKDM4ETDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed